★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN Learn more →

Log In | Become a Member | Sponsor | ⌕ Search

Compliance & EnforcementNews

Archive

News

10,690 articles from the Compliance & Enforcement Brief.

Advertisement

United States: FCPA Resource Guide

Why Did SEC Bypass Books and Records Case Against Exelon?

Former BBG CO Pleads Guilty to Conspiracy to Commit Bribery

DOJ Cracks Down on COVID-Relief Fraud

State Department Contractor Agrees to Pay Civil Penalties Under the Procurement Integrity Act

What DOJ Really Cares About: What Do the Updates to DOJ’s Compliance Guidance Mean in Practice?

Novartis’ FCPA Settlement and New Compliance Guidance

Commentary: Updated FCPA Guidance Contains Misleading Information

The Mighty Amazon Falls to the OFAC Sanctions Sword

Three Cheers for Coordinated Enforcement Actions. But are They Only for Western Countries?

Defense Contractor to Pay Nearly $1 Million to the United States to Resolve Allegation of Overbilling on NSA Contract

California Firm, Employees Indicted in Scheme to Violate the Export Control Reform Act

Relator Had Knowledge of Misconduct but Not Actual False Claims; United States District Court for the Northern District of Ohio No. 1:15cv2355, U.S. ex rel. Girishwar Sharma v. Miraca Life Sciences Inc.

Summary Judgment Inappropriate When Many Facts Remain in Dispute; United States District Court for the Eastern District of Pennsylvania No. 02-2964, U.S. ex rel. Yoash Gohil v. Sanofi U.S. Services Inc., et al.

Federal Contractors’ Compliance Responsibilities Just Got Easier, or Did They?

Is Your Organization Exempted From OFCCP Jurisdiction Under the VA MISSION Act?

Revised FCPA Guidance: Effective Compliance Program and Internal Controls (Part V of V)

At Large: Why Didn’t Novartis Try to Conceal its Ongoing Bribery?

Drug Testing Lab Pays Nearly $12 Million to Settle False Claims Act Allegations

Government Claims Based on AKS Violations False as a Matter of Law; United States District Court for the Middle District of Tennessee, Nashville Division No. 3:13-cv-0760, U.S. ex rel. Gregory M. Goodman v. Arriva Medical LLC, et al.